Syamprasad, NP and Jain, S and Rajdev, B and Panda, SR and Gangasani, JK and Challa, VS and Vaidya, JR and Kundu, GC and Naidu, VGM (2023) AKR1B1 inhibition using NARI-29-an Epalrestat analogue- alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. Chemico-Biological Interactions (381).